Jason A Keyes
CIK 1678152 · Chief Financial Officer · last filed 2026-05-22
Jason A Keyes is a Chief Financial Officer who has filed 42 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for ACTU, was dated May 22, 2026. Across all open-market trades the lifetime net is −$384.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $355.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$355.8K
4
42
-$384.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACTU | Director | — | $2.02 | — | $0 | 3 | 2026-05-22 |
| EQ | Chief Financial Officer | 126,633 | $2.81 | $355.8K | -$384.0K | 30 | 2025-02-19 |
| Carisma Therapeutics Inc. (SESN) Delisted | Director | 40,000 | $12.58 | $503.0K | $0 | 4 | 2022-06-24 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | EVP, Chief Financial Officer | 3,031 | — | — | $0 | 5 | 2017-10-17 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2025-05-23 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | EQ | Mixed | — | $0 | EDGAR |
| 2025-01-24 | EQ | Sell (S) | −10,000 | -$6.5K | EDGAR |
| 2025-01-06 | EQ | Grant (A) | +15,000 | $8.1K | EDGAR |
| 2024-11-15 | EQ | Sell (S) | −10,000 | -$7.0K | EDGAR |
| 2024-09-27 | EQ | Sell (S) | −10,000 | -$8.1K | EDGAR |
| 2024-08-14 | ACTU | Grant (A) | — | $0 | EDGAR |
| 2024-07-18 | EQ | Sell (S) | −10,000 | -$8.7K | EDGAR |
| 2024-01-03 | EQ | Grant (A) | +23,805 | $13.5K | EDGAR |